We are glad to announce that the French Government has renewed GalChimia’s accreditation for Crédit d’Impôt Recherche (CIR) for three additional years (2020, 2021, 2022). GalChimia provides R&D services in chemical development, covering the whole range of specialties needed in the development of new drugs, from synthetic chemistry to analytical and process chemistry. To do so, GalChimia invests in new technologies in order to develop new synthetic methodologies, but also in continuous training for our chemists, looking always to offer the best service to our customers.
Our latest R&D dossier was based on the European project entitled SHIKIFACTORY100. The project aims at the production of compounds of high added value in the chemical, food and cosmetic industries by exploiting well-established microbial transformations. Six world-leading research organizations, four biotechnology companies and one large industrial company have joined efforts in this project that combines chemical and biological syntheses.
El gen AtCDF3 promueve una mayor producción de az...
Un estudio con datos de los últimos 35 años, ind...
Un equipo de investigadores de la Universidad Juli...
En nuestro post hablamos sobre este interesante tipo de célula del si...
Palobiofarma S.L. se complace en anunciar la finalización del tratami...
Portal de biotecnología en España
¡Suscríbase a nuestro newsletter para estar al día con las últimas noticias y ofertas!
2013 © Biotech-Spain.com - Site Developments SL. Todos los derechos reservados. Terminos y Condiciones | Política de Privacidad
Articles
Directory